Multidrug-Resistant Tuberculosis
- 1 July 2006
- Vol. 130 (1) , 261-272
- https://doi.org/10.1016/s0012-3692(15)50981-1
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- The use of macroarrays for the identification of MDR Mycobacterium tuberculosisJournal of Microbiological Methods, 2005
- The DOTS Strategy for Controlling the Global Tuberculosis EpidemicClinics in Chest Medicine, 2005
- Does DOTS work in populations with drug-resistant tuberculosis?The Lancet, 2005
- A Case-Control Study for Multidrug-Resistant Tuberculosis: Risk Factors in Four European CountriesMicrobial Drug Resistance, 2005
- Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatmentBritish Medical Bulletin, 2005
- Standard Short-Course Chemotherapy for Drug-Resistant TuberculosisJAMA, 2000
- First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisonsThe Lancet, 1999
- Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 updateTubercle and Lung Disease, 1998
- Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localitiesAntimicrobial Agents and Chemotherapy, 1997
- An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992